Go Pro

Joint (JYNT) Financials

Joint logo
$8.52 +0.17 (+2.07%)
As of 10:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Joint

Annual Income Statements for Joint

This table shows Joint's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-8.80 -15 18 0.15 3.32 13 7.57 -7.53 -9.75 -5.80 2.91
Consolidated Net Income / (Loss)
-8.80 -15 -3.43 0.15 3.32 13 7.57 -5.80 -9.75 -5.80 2.91
Net Income / (Loss) Continuing Operations
-8.80 -15 18 0.15 3.32 13 7.57 -1.61 -11 -1.61 -0.27
Total Pre-Tax Income
-9.03 -15 -3.40 0.11 3.37 5.41 6.06 -1.61 0.25 -1.61 -0.23
Total Operating Income
-9.32 -15 -3.33 0.14 3.41 5.49 6.13 -1.89 0.32 -1.89 -0.91
Total Gross Profit
11 18 43 32 43 52 72 39 36 41 44
Total Revenue
14 21 50 37 48 59 80 52 47 52 55
Operating Revenue
10 12 50 37 48 59 80 52 47 52 55
Total Cost of Revenue
2.82 2.94 6.45 4.31 5.57 6.51 7.67 13 10 12 11
Operating Cost of Revenue
2.82 2.94 6.45 4.31 5.57 6.51 7.67 13 10 12 11
Total Operating Expenses
20 33 25 32 39 47 66 43 36 43 45
Selling, General & Admin Expense
16 22 18 25 31 36 51 30 26 30 30
Marketing Expense
2.84 4.42 4.47 4.82 6.91 7.80 11 11 8.69 11 13
Depreciation Expense
1.27 2.57 2.02 1.56 1.90 2.73 3.92 1.37 1.28 1.37 1.64
Impairment Charge
0.00 3.52 0.42 0.59 0.11 -0.05 0.03 0.07 -0.02 0.07 0.01
Total Other Income / (Expense), net
0.28 -0.00 -0.06 -0.03 -0.04 -0.08 -0.07 0.00 -0.06 0.28 0.68
Other Income / (Expense), net
0.28 -0.00 -0.06 -0.03 -0.04 -0.08 -0.07 0.00 -0.06 0.28 0.68
Income Tax Expense
-0.24 0.16 0.04 -0.04 0.05 -7.75 -1.51 0.01 11 0.01 0.04
Net Income / (Loss) Discontinued Operations
- - - - - - - -4.18 1.02 -4.18 3.18
Basic Earnings per Share
($0.88) ($1.20) ($0.26) $0.01 $0.24 $0.94 $0.53 ($0.39) ($0.66) ($0.39) $0.19
Weighted Average Basic Shares Outstanding
10.04M 12.70M 13.25M 13.67M 13.82M 14.00M 14.32M 0.00 14.69M 14.92M 15.13M
Diluted Earnings per Share
($0.88) ($1.20) ($0.26) $0.01 $0.23 $0.90 $0.51 ($0.38) ($0.65) ($0.38) $0.19
Weighted Average Diluted Shares Outstanding
10.04M 12.70M 13.25M 14.03M 14.47M 14.58M 14.94M 0.00 14.94M 15.15M 15.19M
Weighted Average Basic & Diluted Shares Outstanding
10.04M 12.70M 13.25M 13.74M 13.88M 14.14M 14.42M 14.57M 14.78M 15.17M 14.11M

Quarterly Income Statements for Joint

This table shows Joint's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.72 -11 0.95 -3.60 -3.17 -2.72 0.97 0.09 0.86 0.99 1.30
Consolidated Net Income / (Loss)
-0.72 -11 0.95 -3.60 -3.17 -2.72 0.97 0.09 0.86 0.99 1.30
Net Income / (Loss) Continuing Operations
-0.72 -12 -0.40 -1.71 -0.41 4.28 -0.51 -0.99 0.29 0.94 1.10
Total Pre-Tax Income
-0.90 -1.53 -0.39 -1.70 -0.41 3.92 -0.49 -0.98 0.30 0.94 1.11
Total Operating Income
-0.90 2.24 -0.43 -1.78 -0.49 3.84 -0.68 -1.14 0.16 0.74 0.87
Total Gross Profit
27 -43 9.48 9.80 9.84 -41 10 10 11 12 12
Total Revenue
29 -40 12 13 13 -38 13 13 13 15 15
Operating Revenue
29 -40 12 13 13 -38 13 13 13 15 15
Total Cost of Revenue
2.60 2.81 2.70 2.81 2.81 3.15 2.97 2.77 2.66 2.82 2.72
Operating Cost of Revenue
2.60 2.81 2.70 2.81 2.81 3.15 2.97 2.77 2.66 2.82 2.72
Total Operating Expenses
28 -45 9.91 12 10 -45 11 12 11 12 11
Selling, General & Admin Expense
20 -34 7.34 7.79 7.48 -34 6.91 7.75 7.30 7.68 7.08
Marketing Expense
4.30 -4.48 2.24 3.44 2.50 -3.13 3.51 3.48 2.82 3.49 3.72
Depreciation Expense
2.35 -5.62 0.33 0.34 0.35 -2.80 0.36 0.40 0.45 0.43 0.40
Impairment Charge
0.90 -1.07 0.00 0.00 0.00 -5.59 0.00 0.00 0.00 0.00 0.03
Total Other Income / (Expense), net
-0.01 -3.77 0.04 0.08 0.08 0.08 0.19 0.16 0.14 0.20 0.24
Other Income / (Expense), net
-0.01 -3.77 0.04 0.08 0.08 0.08 0.19 0.16 0.14 0.20 0.24
Income Tax Expense
-0.19 11 0.01 0.01 0.01 -0.36 0.01 0.01 0.01 0.00 0.01
Net Income / (Loss) Discontinued Operations
- - 1.35 -1.89 -2.75 - 1.47 1.08 0.56 0.05 0.20
Basic Earnings per Share
($0.05) ($0.75) $0.06 ($0.24) ($0.21) ($0.18) $0.06 $0.01 $0.06 $0.06 $0.09
Weighted Average Basic Shares Outstanding
14.79M 14.69M 14.80M 14.95M 14.96M 14.92M 15.19M 15.33M 15.34M 15.13M 14.18M
Diluted Earnings per Share
($0.05) ($0.74) $0.06 ($0.24) ($0.21) ($0.17) $0.06 $0.01 $0.06 $0.06 $0.09
Weighted Average Diluted Shares Outstanding
15.02M 14.94M 15.01M 15.21M 15.19M 15.15M 15.26M 15.40M 15.40M 15.19M 14.19M
Weighted Average Basic & Diluted Shares Outstanding
14.75M 14.78M 14.97M 15.00M 14.98M 15.17M 15.30M 15.34M 14.87M 14.11M 14.26M

Annual Cash Flow Statements for Joint

This table details how cash moves in and out of Joint's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-4.00 -14 0.98 4.53 -0.21 12 -0.91 -9.36 8.66 6.78 -1.69
Net Cash From Operating Activities
-6.80 -11 -0.07 5.45 7.52 11 14 8.21 15 9.42 1.84
Net Cash From Continuing Operating Activities
-6.80 -11 -0.07 5.45 7.52 11 14 8.21 15 9.42 1.84
Net Income / (Loss) Continuing Operations
-8.80 -15 -3.43 0.15 3.32 13 7.57 0.63 -9.75 -5.80 2.91
Consolidated Net Income / (Loss)
-8.80 -15 -3.43 0.15 3.32 13 7.57 0.63 -9.75 -5.80 2.91
Depreciation Expense
1.27 2.57 2.02 1.56 1.90 2.73 3.92 6.65 8.58 4.72 1.71
Non-Cash Adjustments To Reconcile Net Income
-0.50 4.25 0.88 0.98 0.70 0.83 0.48 1.62 3.55 9.44 6.40
Changes in Operating Assets and Liabilities, net
1.24 -2.49 0.46 2.77 1.60 -5.55 1.88 -0.68 12 1.05 -9.18
Net Cash From Investing Activities
-10 -2.70 -0.37 -1.24 -7.14 -4.60 -13 -18 -6.19 -0.63 6.27
Net Cash From Continuing Investing Activities
-10 -2.70 -0.37 -1.24 -7.14 -4.60 -13 -18 -6.19 -0.63 6.27
Purchase of Property, Plant & Equipment
-4.07 -1.57 -0.45 -1.11 -3.48 -3.16 -6.99 -5.90 -5.00 -1.19 -1.50
Divestitures
- - - - - - 0.00 0.11 0.00 0.55 7.78
Net Cash From Financing Activities
13 -0.24 1.42 0.33 -0.60 5.60 -2.00 0.33 0.17 -2.00 -9.81
Net Cash From Continuing Financing Activities
13 -0.24 1.42 0.33 -0.60 5.60 -2.00 0.33 0.17 -2.00 -9.81
Repayment of Debt
-0.22 -0.44 -0.23 0.00 -1.10 0.00 -2.73 - 0.00 -2.00 0.00
Repurchase of Common Equity
0.00 -0.08 -0.00 -0.00 -0.02 -0.03 -0.71 -0.01 -0.00 0.00 -11
Other Financing Activities, net
-1.35 0.07 0.36 0.33 0.52 3.68 1.44 0.33 0.18 -0.00 1.51
Cash Interest Paid
- - - - - - - - 0.17 0.07 0.05
Cash Income Taxes Paid
- - - - - - - - 0.57 0.61 0.63

Quarterly Cash Flow Statements for Joint

This table details how cash moves in and out of Joint's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
2.69 2.07 0.45 -1.02 3.35 4.00 -3.10 8.10 -0.29 -6.41 -2.88
Net Cash From Operating Activities
3.80 3.38 2.81 -0.97 3.45 4.13 -3.70 0.87 1.77 2.90 -1.48
Net Cash From Continuing Operating Activities
3.80 3.38 2.81 -0.97 3.45 4.13 -3.70 0.87 1.77 2.90 -1.47
Net Income / (Loss) Continuing Operations
-0.72 -11 0.95 -3.60 -3.17 -2.72 0.97 0.26 0.86 0.99 1.30
Consolidated Net Income / (Loss)
-0.72 -11 0.95 -3.60 -3.17 -2.72 0.97 0.26 0.86 0.99 1.30
Depreciation Expense
2.35 1.69 1.40 1.52 1.24 0.56 0.39 0.42 0.46 0.44 0.40
Non-Cash Adjustments To Reconcile Net Income
1.68 1.40 0.82 1.79 4.48 5.06 1.26 1.78 1.20 2.00 0.37
Changes in Operating Assets and Liabilities, net
0.49 11 -0.36 -0.69 0.90 1.23 -6.31 -1.59 -0.75 -0.54 -3.54
Net Cash From Investing Activities
-1.10 -1.30 -0.34 -0.09 -0.09 -0.10 -0.29 7.23 -0.32 -0.35 -0.23
Net Cash From Continuing Investing Activities
-1.10 -1.30 -0.34 -0.09 -0.09 -0.10 -0.29 7.23 -0.32 -0.35 -0.23
Purchase of Property, Plant & Equipment
-1.10 -1.17 -0.40 -0.26 -0.24 -0.28 -0.33 -0.51 -0.32 -0.35 -0.23
Divestitures
- - 0.05 0.17 0.15 0.18 0.04 7.74 - - 0.00
Net Cash From Financing Activities
-0.01 -0.01 -2.01 0.04 -0.01 -0.02 0.89 - -1.74 -8.96 -1.16
Net Cash From Continuing Financing Activities
-0.01 -0.01 -2.01 0.04 -0.01 -0.02 0.89 - -1.74 -8.96 -1.16
Repurchase of Common Equity
-0.00 -0.00 -0.01 -0.00 0.01 - 0.00 - -2.28 -9.02 -1.15
Other Financing Activities, net
-0.01 -0.01 -0.01 0.05 -0.02 -0.02 0.89 - 0.54 0.07 -0.02
Cash Interest Paid
0.04 0.01 0.02 0.01 0.03 0.01 0.01 0.01 0.01 0.01 0.01
Cash Income Taxes Paid
0.41 0.10 0.00 0.41 0.10 0.10 -0.06 0.44 0.16 0.08 0.00

Annual Balance Sheets for Joint

This table presents Joint's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
33 17 18 23 44 66 87 93 87 83 61
Total Current Assets
19 5.70 6.67 11 13 25 27 18 44 75 52
Cash & Equivalents
17 3.01 4.22 8.72 8.46 21 20 9.75 18 25 24
Restricted Cash
0.39 0.33 0.10 0.14 0.19 0.27 0.39 0.81 1.06 0.95 0.70
Accounts Receivable
0.74 1.02 1.14 0.81 2.65 2.06 3.70 3.91 2.58 2.59 2.85
Prepaid Expenses
0.37 0.50 0.54 0.88 1.12 1.57 2.28 2.10 1.84 1.79 1.74
Other Current Assets
0.61 0.75 0.50 0.61 0.77 0.90 0.99 1.05 1.05 1.06 0.95
Other Current Nonoperating Assets
- - - - - - - - 20 43 22
Plant, Property, & Equipment, net
7.14 4.72 3.80 3.66 6.58 0.00 0.00 0.00 3.81 3.21 3.16
Total Noncurrent Assets
7.20 6.63 7.96 8.47 24 41 60 76 39 5.37 5.72
Other Noncurrent Operating Assets
2.17 1.54 2.94 3.48 16 25 39 45 5.92 5.37 5.72
Total Liabilities & Shareholders' Equity
33 17 18 23 44 66 87 93 87 83 61
Total Liabilities
13 10 17 23 38 45 57 61 62 62 46
Total Current Liabilities
7.49 5.86 5.38 10 14 18 21 23 34 49 33
Accounts Payable
2.00 1.05 1.07 1.25 1.53 1.56 1.71 2.97 1.25 1.75 1.59
Accrued Expenses
0.38 0.30 0.09 0.27 0.22 0.77 1.81 1.07 1.16 1.51 1.50
Current Deferred Revenue
2.91 3.29 3.01 5.04 5.94 6.68 7.66 9.94 2.52 2.55 2.52
Current Employee Benefit Liabilities
1.49 0.75 0.87 2.04 2.84 2.78 3.91 2.03 0.86 3.55 4.06
Other Current Liabilities
0.26 0.13 0.24 0.58 3.04 6.67 6.36 7.21 2.32 2.32 1.78
Other Current Nonoperating Liabilities
- - - - - - - 0.00 25 37 21
Total Noncurrent Liabilities
5.20 4.27 12 12 24 26 35 38 29 13 13
Noncurrent Deferred Revenue
4.83 3.63 10 12 - 14 13 14 14 12 11
Other Noncurrent Operating Liabilities
0.24 0.51 0.41 0.39 24 0.16 20 21 1.52 0.98 2.17
Commitments & Contingencies
0.00 0.00 0.00 0.00 - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
21 6.93 1.15 0.73 5.72 21 30 33 25 21 15
Total Preferred & Common Equity
21 6.93 1.15 0.73 5.72 21 30 33 25 21 15
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
21 6.93 1.15 0.73 5.72 21 30 33 25 21 15
Common Stock
35 36 37 38 39 41 44 46 48 49 52
Retained Earnings
-14 -29 -36 -37 -34 -20 -13 -12 -22 -28 -25
Treasury Stock
-0.79 -0.50 -0.09 -0.09 -0.11 -0.14 -0.85 -0.86 -0.86 -0.87 -12
Noncontrolling Interest
- - - 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.03

Quarterly Balance Sheets for Joint

This table presents Joint's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
99 86 82 80 80 73 69 58
Total Current Assets
28 45 43 55 71 64 61 50
Cash & Equivalents
16 19 17 21 22 30 30 21
Restricted Cash
1.09 0.92 1.19 1.26 0.98 1.19 1.01 0.74
Accounts Receivable
3.65 3.27 3.58 4.30 2.97 2.79 2.90 2.34
Prepaid Expenses
2.60 2.93 3.44 2.49 3.80 2.71 2.06 3.14
Other Current Assets
5.03 19 18 26 1.05 0.97 1.11 0.90
Other Current Nonoperating Assets
- - - - 40 26 24 22
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 3.06 3.18 3.04 3.04
Total Noncurrent Assets
70 41 39 24 6.30 6.26 5.85 5.29
Other Noncurrent Operating Assets
41 28 26 19 6.30 6.26 5.85 5.29
Total Liabilities & Shareholders' Equity
99 86 82 80 80 73 69 58
Total Liabilities
63 59 59 59 57 50 47 42
Total Current Liabilities
28 33 34 38 43 36 33 30
Accounts Payable
1.88 1.28 1.64 1.90 1.02 1.58 1.20 0.96
Accrued Expenses
2.49 1.96 3.16 4.09 2.01 1.28 0.76 1.61
Current Deferred Revenue
9.05 7.13 6.94 5.72 2.53 2.58 2.52 2.49
Current Employee Benefit Liabilities
3.88 4.51 4.27 6.11 2.19 2.39 3.42 2.10
Other Current Liabilities
7.41 5.63 5.86 5.34 2.21 2.29 2.26 1.81
Other Current Nonoperating Liabilities
2.97 13 12 15 33 25 23 21
Total Noncurrent Liabilities
36 26 25 21 15 14 14 12
Noncurrent Deferred Revenue
14 13 13 13 12 12 11 10
Other Noncurrent Operating Liabilities
20 13 12 8.14 2.61 2.48 2.33 2.05
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
35 26 23 20 23 23 23 15
Total Preferred & Common Equity
35 26 23 20 23 23 23 15
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
35 26 23 20 23 23 23 15
Common Stock
47 48 49 49 50 51 52 52
Retained Earnings
-11 -21 -25 -28 -27 -27 -26 -23
Treasury Stock
-0.86 -0.87 -0.87 -0.87 -0.88 -0.88 -3.17 -13
Noncontrolling Interest
0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03

Annual Metrics And Ratios for Joint

This table displays calculated financial ratios and metrics derived from Joint's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
9,906,491.00 12,720,399.00 13,518,146.00 13,734,193.00 13,863,085.00 14,041,146.00 14,413,339.00 14,529,679.00 14,754,287.00 - 14,866,192.00
DEI Adjusted Shares Outstanding
9,906,491.00 12,720,399.00 13,518,146.00 13,734,193.00 13,863,085.00 14,041,146.00 14,413,339.00 14,529,679.00 14,754,287.00 - 14,866,192.00
DEI Earnings Per Adjusted Shares Outstanding
-0.89 -1.19 1.35 0.01 0.24 0.94 0.52 -0.52 -0.66 - 0.20
Growth Metrics
- - - - - - - - - - -
Revenue Growth
94.41% 48.34% 142.83% -26.44% 32.16% 21.12% 36.34% -34.80% -9.94% 10.47% 5.24%
EBITDA Growth
-424.38% -60.26% 88.92% 220.74% 216.58% 54.55% 22.47% -52.32% 85.73% -63.25% -52.33%
EBIT Growth
-434.26% -66.16% 77.37% 103.21% 2,994.87% 60.50% 11.89% -131.19% 113.45% -680.60% 85.73%
NOPAT Growth
-472.72% -61.09% 77.80% 108.23% 1,653.50% 297.01% -42.72% -117.28% -920.58% 90.90% 51.65%
Net Income Growth
-190.22% -72.48% 77.38% 104.27% 2,165.71% 296.16% -42.55% -176.63% -68.23% 12.53% 150.15%
EPS Growth
-57.14% -36.36% 78.33% 103.85% 2,200.00% 291.30% -43.33% -174.51% -71.05% 13.85% 150.00%
Operating Cash Flow Growth
-1,453.68% -59.60% 99.32% 7,454.91% 37.96% 48.67% 23.79% -40.70% 78.79% -35.85% -80.47%
Free Cash Flow Firm Growth
-2,856.74% 35.40% 135.29% 41.29% -114.37% -237.54% 424.29% -259.60% 243.99% -89.75% -193.55%
Invested Capital Growth
175.70% -4.17% -152.82% -240.04% 58.43% 542.92% -3.52% 93.05% -133.30% -39.11% 9.02%
Revenue Q/Q Growth
14.08% 10.91% 67.84% -30.33% 8.77% 5.70% 5.56% -44.99% -59.06% -57.04% 0.83%
EBITDA Q/Q Growth
-32.26% -17.95% 79.29% 67.39% 24.42% 22.70% -23.18% 10.82% -27.20% 924.50% -3.95%
EBIT Q/Q Growth
-33.60% -16.31% 61.70% 116.66% 32.04% 35.76% -24.69% -2,889.79% -92.00% 73.37% 18.24%
NOPAT Q/Q Growth
-37.79% -17.33% 62.26% 144.17% 33.58% 242.64% -56.86% -225.90% -4,432.51% 69.43% -7.96%
Net Income Q/Q Growth
-10.19% -18.60% 61.78% 129.15% 34.64% 244.12% -56.94% -1,275.48% -575.10% 49.40% 50.34%
EPS Q/Q Growth
13.73% -12.15% 62.86% 133.33% 35.29% 233.33% -57.14% -1,366.67% -564.29% 50.44% 35.71%
Operating Cash Flow Q/Q Growth
-56.90% 17.39% 96.46% 60.00% -9.04% 15.00% -17.24% 85.53% -10.89% 8.62% -40.14%
Free Cash Flow Firm Q/Q Growth
0.00% 35.00% 896.71% -13.17% 92.16% -113.66% 183.66% -229.29% 179.84% -65.38% -107.51%
Invested Capital Q/Q Growth
129.25% -55.18% -168.72% -109.05% -133.95% 322.99% 37.52% 19,771.98% -134.65% -181.95% -14.36%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
79.62% 85.68% 87.06% 88.24% 88.51% 88.91% 90.42% 75.14% 77.69% 77.81% 79.55%
EBITDA Margin
-56.12% -60.63% -2.77% 4.54% 10.88% 13.88% 12.47% 9.12% 18.81% 6.26% 2.70%
Operating Margin
-67.34% -73.13% -6.69% 0.39% 7.05% 9.36% 7.66% -3.62% 0.68% -3.38% -1.66%
EBIT Margin
-65.29% -73.13% -6.82% 0.30% 6.96% 9.22% 7.57% -3.62% 0.54% -2.84% -0.42%
Profit (Net Income) Margin
-63.59% -73.93% -6.89% 0.40% 6.86% 22.44% 9.46% -11.11% -20.76% -16.44% 5.30%
Tax Burden Percent
97.39% 101.10% 101.06% 134.62% 98.56% 243.27% 124.92% 360.34% -3,839.36% 578.38% -1,266.76%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 85.16% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% -34.62% 1.44% -143.27% -24.92% 0.00% 4,339.82% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -262.78% -252.70% 0.00% 0.00% 266.74% 60.20% -7.23% -167.90% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -215.17% -217.40% 0.00% 0.00% 269.03% 60.87% 26.78% -186.03% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 152.84% 167.72% 0.00% 0.00% -168.64% -30.78% -11.20% 133.89% 0.00% 0.00%
Return on Equity (ROE)
-48.46% -109.94% -84.97% 15.60% 103.09% 98.09% 29.42% -18.43% -34.00% -39.94% 16.26%
Cash Return on Invested Capital (CROIC)
-391.83% -258.52% 0.00% 0.00% 0.00% -19.32% 63.78% -70.73% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-29.22% -59.54% -19.14% 0.52% 10.05% 9.88% 7.92% -2.09% 0.28% -1.76% -0.32%
Return on Assets (ROA)
-28.45% -60.19% -19.34% 0.70% 9.90% 24.03% 9.89% -6.42% -10.79% -10.18% 4.03%
Return on Common Equity (ROCE)
-48.46% -109.94% -84.97% 15.60% 103.09% 98.09% 29.40% -18.42% -33.97% -39.89% 16.24%
Return on Equity Simple (ROE_SIMPLE)
-42.54% -219.10% -297.58% 20.16% 58.10% 62.33% 24.98% 0.00% 0.00% -47.60% 0.00%
Net Operating Profit after Tax (NOPAT)
-6.52 -11 -2.33 0.19 3.37 13 7.65 -1.32 -13 -1.23 -0.64
NOPAT Margin
-47.14% -51.19% -4.68% 0.52% 6.95% 22.77% 9.56% -2.54% -28.73% -2.37% -1.16%
Net Nonoperating Expense Percent (NNEP)
-12.10% -47.61% -35.30% -0.82% -0.51% -2.30% -0.67% -34.01% 18.13% -23.59% 12.45%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.82% -50.41% -6.85% -4.24%
Cost of Revenue to Revenue
20.38% 14.32% 12.94% 11.76% 11.49% 11.09% 9.58% 24.86% 22.31% 22.19% 20.45%
SG&A Expenses to Revenue
117.23% 107.61% 36.35% 68.84% 63.04% 61.68% 63.55% 57.75% 55.84% 57.49% 53.98%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
146.96% 158.80% 50.22% 87.85% 81.46% 79.55% 82.76% 81.54% 77.01% 81.19% 81.22%
Earnings before Interest and Taxes (EBIT)
-9.03 -15 -3.40 0.11 3.37 5.41 6.06 -1.89 0.25 -1.47 -0.23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-7.76 -12 -1.38 1.67 5.27 8.15 9.98 4.76 8.84 3.25 1.48
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.86 4.87 58.13 157.07 39.11 17.45 31.26 6.24 5.73 8.89 8.61
Price to Tangible Book Value (P/TBV)
3.77 18.36 0.00 0.00 0.00 27.04 46.22 15.46 5.73 8.89 8.61
Price to Revenue (P/Rev)
4.27 1.64 1.35 3.12 4.62 6.28 11.83 3.89 3.02 3.07 2.36
Price to Earnings (P/E)
0.00 0.00 3.67 778.95 67.32 28.00 125.16 0.00 0.00 0.00 44.59
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 27.24% 0.13% 1.49% 3.57% 0.80% 0.00% 0.00% 0.00% 2.24%
Enterprise Value to Invested Capital (EV/IC)
10.42 7.85 0.00 0.00 0.00 27.86 74.41 8.08 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.08 1.50 1.28 2.91 4.44 6.14 11.61 3.73 2.65 2.57 1.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 63.96 40.80 44.25 93.11 40.92 14.10 41.05 70.98
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 977.48 63.78 66.61 153.40 0.00 490.54 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 554.99 63.92 26.98 121.40 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 19.54 28.60 32.24 67.11 23.71 8.49 14.16 57.31
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 17.50 20.67 0.00 0.00 114.59 0.00 6.69 69.78 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.03 0.05 0.95 1.51 0.00 0.60 0.07 0.06 0.08 0.00 0.00
Long-Term Debt to Equity
0.01 0.00 0.87 0.00 0.00 0.60 0.07 0.06 0.08 0.00 0.00
Financial Leverage
-1.04 -0.71 -0.77 -5.83 -2.54 -0.63 -0.51 -0.42 -0.72 -1.45 -1.59
Leverage Ratio
1.70 1.83 4.39 22.26 10.41 4.08 2.97 2.87 3.15 3.92 4.03
Compound Leverage Factor
1.70 1.83 4.39 22.26 10.41 4.08 2.97 2.44 3.15 3.92 4.03
Debt to Total Capital
2.74% 4.57% 48.81% 60.19% 0.00% 37.42% 6.44% 5.96% 7.47% 0.00% 0.00%
Short-Term Debt to Total Capital
2.13% 4.57% 4.44% 60.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.61% 0.00% 44.38% 0.00% 0.00% 37.42% 6.44% 5.96% 7.47% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.08% 0.07% 0.09% 0.14% 0.17%
Common Equity to Total Capital
97.26% 95.43% 51.19% 39.81% 100.00% 62.58% 93.48% 93.97% 92.44% 99.86% 99.83%
Debt to EBITDA
-0.07 -0.03 -0.80 0.66 0.00 1.55 0.21 0.43 0.23 0.00 0.00
Net Debt to EBITDA
2.14 0.24 2.33 -4.66 0.00 -1.00 -1.79 -1.78 -1.95 0.00 0.00
Long-Term Debt to EBITDA
-0.02 0.00 -0.73 0.00 0.00 1.55 0.21 0.43 0.23 0.00 0.00
Debt to NOPAT
-0.09 -0.03 -0.47 5.73 0.00 0.95 0.27 -1.56 -0.15 0.00 0.00
Net Debt to NOPAT
2.54 0.29 1.38 -40.41 0.00 -0.61 -2.33 6.42 1.28 0.00 0.00
Long-Term Debt to NOPAT
-0.02 0.00 -0.43 0.00 0.00 0.95 0.27 -1.56 -0.15 0.00 0.00
Altman Z-Score
2.15 -2.10 1.77 2.42 3.81 5.80 11.03 2.24 1.71 1.93 2.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.05% 0.08% 0.09% 0.12% 0.14%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.54 0.97 1.24 1.10 0.98 1.37 1.25 0.76 1.32 1.46 1.59
Quick Ratio
2.35 0.69 1.03 0.94 0.83 1.23 1.08 0.59 0.62 0.56 0.81
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-16 -10 3.65 5.15 -0.74 -2.50 8.11 -13 19 1.91 -1.64
Operating Cash Flow to CapEx
-167.63% -691.91% -16.50% 490.70% 215.93% 354.32% 198.07% 139.17% 293.61% 794.09% 122.26%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.45 0.81 2.81 1.75 1.44 1.07 1.05 0.58 0.52 0.62 0.76
Accounts Receivable Turnover
19.11 23.26 46.14 37.70 28.08 24.93 27.76 13.71 14.47 20.09 20.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3.34 3.46 11.69 9.83 9.46 0.00 0.00 0.00 0.00 14.89 17.25
Accounts Payable Turnover
1.78 1.93 6.07 3.71 4.01 4.22 4.69 5.55 4.97 7.67 6.72
Days Sales Outstanding (DSO)
19.10 15.69 7.91 9.68 13.00 14.64 13.15 26.63 25.22 18.17 18.07
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
205.54 189.47 60.10 98.31 91.12 86.59 77.79 65.74 73.49 47.62 54.29
Cash Conversion Cycle (CCC)
-186.44 -173.78 -52.19 -88.63 -78.12 -71.95 -64.64 -39.11 -48.27 -29.45 -36.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4.08 3.91 -2.07 -7.03 -2.92 13 12 24 -8.03 -11 -10
Invested Capital Turnover
-21.11 5.13 53.99 -8.06 -9.74 11.72 6.29 2.85 5.84 -5.41 -5.18
Increase / (Decrease) in Invested Capital
9.48 -0.17 -5.98 -4.96 4.11 16 -0.46 12 -32 -3.14 1.00
Enterprise Value (EV)
43 31 64 107 215 361 929 195 125 133 105
Market Capitalization
59 34 67 114 224 369 947 203 142 159 130
Book Value per Share
$2.09 $0.54 $0.09 $0.05 $0.41 $1.50 $2.10 $2.24 $1.68 $1.20 $1.01
Tangible Book Value per Share
$1.58 $0.14 ($0.26) ($0.30) ($0.12) $0.97 $1.42 $0.90 $1.68 $1.20 $1.01
Total Capital
21 7.26 2.25 1.83 5.72 34 32 35 27 18 15
Total Debt
0.58 0.33 1.10 1.10 0.00 13 2.09 2.06 2.00 0.00 0.00
Total Long-Term Debt
0.13 0.00 1.00 0.00 0.00 13 2.09 2.06 2.00 0.00 0.00
Net Debt
-17 -3.01 -3.22 -7.75 -8.64 -8.19 -18 -8.49 -17 -26 -24
Capital Expenditures (CapEx)
4.05 1.57 0.45 1.11 3.48 3.16 6.99 5.90 5.00 1.19 1.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.19 -3.18 -2.93 -6.72 -8.90 -14 -14 -16 -8.45 -3.16 -5.03
Debt-free Net Working Capital (DFNWC)
12 0.16 1.39 2.13 -0.26 6.89 5.45 -5.60 11 23 19
Net Working Capital (NWC)
12 -0.17 1.29 1.03 -0.26 6.89 5.45 -5.60 11 23 19
Net Nonoperating Expense (NNE)
2.28 4.67 1.10 0.05 0.04 0.19 0.09 4.47 -3.74 7.30 -3.55
Net Nonoperating Obligations (NNO)
-17 -3.01 -3.22 -7.75 -8.64 -8.19 -18 -8.49 -33 -29 -25
Total Depreciation and Amortization (D&A)
1.27 2.57 2.02 1.56 1.90 2.73 3.92 6.65 8.58 4.72 1.71
Debt-free, Cash-free Net Working Capital to Revenue
-37.50% -15.49% -5.88% -18.34% -18.38% -23.74% -18.07% -30.97% -17.99% -6.08% -9.16%
Debt-free Net Working Capital to Revenue
86.66% 0.80% 2.79% 5.81% -0.54% 11.74% 6.81% -10.74% 22.91% 44.01% 35.11%
Net Working Capital to Revenue
83.39% -0.81% 2.59% 2.81% -0.54% 11.74% 6.81% -10.74% 22.91% 44.01% 35.11%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.88) ($1.20) ($0.25) $0.02 $0.24 $0.94 $0.46 $0.08 ($0.66) ($0.57) $0.19
Adjusted Weighted Average Basic Shares Outstanding
12.58M 13.05M 13.59M 13.67M 13.82M 14.00M 14.32M 14.49M 14.69M 14.92M 15.13M
Adjusted Diluted Earnings per Share
($0.88) ($1.20) ($0.25) $0.02 $0.23 $0.90 $0.44 $0.08 ($0.65) ($0.56) $0.19
Adjusted Weighted Average Diluted Shares Outstanding
12.58M 13.05M 13.59M 14.03M 14.47M 14.58M 14.94M 14.87M 14.94M 15.15M 15.19M
Adjusted Basic & Diluted Earnings per Share
($0.88) ($1.20) ($0.25) $0.00 $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
10.04M 12.70M 13.25M 13.74M 13.88M 14.14M 14.42M 14.57M 14.78M 15.17M 14.11M
Normalized Net Operating Profit after Tax (NOPAT)
-6.52 -8.04 -2.04 0.52 3.48 3.81 4.31 -1.28 0.21 -1.22 -0.63
Normalized NOPAT Margin
-47.14% -39.18% -4.09% 1.41% 7.18% 6.49% 5.38% -2.45% 0.44% -2.35% -1.15%
Pre Tax Income Margin
-65.29% -73.13% -6.82% 0.30% 6.96% 9.22% 7.57% -3.08% 0.54% -2.84% -0.42%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.56% -0.08% 3.28% 0.61% 0.24% 9.36% -0.10% -0.04% -0.11% 389.15%

Quarterly Metrics And Ratios for Joint

This table displays calculated financial ratios and metrics derived from Joint's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
14,754,553.00 14,754,287.00 14,776,243.00 14,973,910.00 14,996,775.00 - 30,349,862.00 30,605,544.00 15,343,377.00 14,866,192.00 14,114,334.00
DEI Adjusted Shares Outstanding
14,754,553.00 14,754,287.00 14,776,243.00 14,973,910.00 14,996,775.00 - 30,349,862.00 30,605,544.00 15,343,377.00 14,866,192.00 14,114,334.00
DEI Earnings Per Adjusted Shares Outstanding
-0.05 -0.75 0.06 -0.24 -0.21 - 0.03 0.00 0.06 0.07 0.09
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.43% -87.31% -56.95% -56.97% -57.07% 4.54% 7.33% 5.24% 5.74% 3.08% 13.33%
EBITDA Growth
-41.90% -81.75% -81.17% -109.47% -42.54% 2,697.10% -110.29% -219.26% -8.01% -4.23% 1,555.74%
EBIT Growth
-227.89% -28.30% -112.32% -253.14% 54.77% 356.43% -26.20% 42.42% 173.53% 5.76% 326.12%
NOPAT Growth
-183.02% 279.21% 37.73% -375.05% 45.12% 166.67% -59.06% 36.03% 145.04% -10.62% 282.11%
Net Income Growth
-197.97% -95.07% -59.29% -1,022.16% -341.89% 75.41% 2.20% 102.60% 127.01% 5,510.51% 34.24%
EPS Growth
-200.00% -100.00% -62.50% -1,100.00% -320.00% 77.03% 0.00% 104.17% 128.57% 500.00% 50.00%
Operating Cash Flow Growth
-9.86% -34.66% -53.35% -166.29% -9.30% 22.09% -231.68% 189.23% -48.58% -29.85% 60.11%
Free Cash Flow Firm Growth
-343.62% 369.72% 108.18% 121.42% 138.84% -78.25% 1,111.70% 367.50% 145.99% -106.71% -99.82%
Invested Capital Growth
18,995.46% -133.30% -11.27% -27.99% -41.18% -39.11% -137.76% -151.71% -164.83% 9.02% 11.16%
Revenue Q/Q Growth
0.57% -236.07% 130.38% 3.49% 0.35% -226.78% -11.12% 1.47% 0.83% 13.35% -2.29%
EBITDA Q/Q Growth
-21.82% -88.93% 533.51% -117.27% 574.31% 340.17% -107.22% -435.79% 236.67% 81.15% 9.74%
EBIT Q/Q Growth
-87.97% -69.05% 74.47% -335.23% 75.93% 226.35% -155.38% -98.58% 130.74% 212.80% 18.42%
NOPAT Q/Q Growth
-139.76% 349.88% -119.01% -317.10% 72.30% 287.83% -157.40% -67.74% 119.50% 376.02% 16.94%
Net Income Q/Q Growth
-123.49% -1,441.54% 108.58% -479.78% 11.99% 14.21% 5,378.61% -88.35% 815.79% 15.92% 31.08%
EPS Q/Q Growth
-150.00% -1,380.00% 108.11% -500.00% 12.50% 19.05% 500.00% -80.00% 500.00% 0.00% 50.00%
Operating Cash Flow Q/Q Growth
158.87% -11.02% -16.92% -134.64% 454.21% 19.78% -189.60% 123.47% 104.11% 63.42% -150.95%
Free Cash Flow Firm Q/Q Growth
3.58% 242.38% -93.57% 142.67% 74.81% 0.29% 572.48% -6.58% -8.02% -101.16% 118.03%
Invested Capital Q/Q Growth
-0.31% -134.65% 341.78% -13.79% -18.56% -181.95% 34.01% -17.12% -2.11% -14.36% 35.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
91.16% 0.00% 77.80% 77.70% 77.76% 0.00% 77.27% 79.11% 80.11% 81.41% 81.63%
EBITDA Margin
4.90% 0.00% 8.32% -1.39% 6.56% 0.00% -0.80% -4.21% 5.71% 9.12% 10.25%
Operating Margin
-3.05% 0.00% -3.50% -14.11% -3.89% 0.00% -5.19% -8.58% 1.20% 4.89% 5.90%
EBIT Margin
-3.07% 0.00% -3.20% -13.47% -3.23% 0.00% -3.77% -7.37% 2.25% 6.20% 7.52%
Profit (Net Income) Margin
-2.43% 0.00% 7.77% -28.52% -25.01% 0.00% 7.40% 0.70% 6.39% 6.53% 8.77%
Tax Burden Percent
79.21% 722.30% -242.61% 211.70% 773.89% -69.27% -196.46% -9.54% 284.32% 105.36% 116.63%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% -9.12% 0.00% 0.00% 3.44% 0.37% 1.00%
Return on Invested Capital (ROIC)
-21.03% 0.00% -3.67% -7.00% 0.00% 0.00% -31.91% -79.44% 26.39% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-20.62% 0.00% -15.97% 18.10% 0.00% 0.00% -39.72% -84.08% 22.75% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
13.43% 0.00% 5.26% -5.78% 0.00% 0.00% 29.94% 69.46% -20.23% 0.00% 0.00%
Return on Equity (ROE)
-7.59% 0.00% 1.59% -12.78% -60.46% -39.94% -1.97% -9.98% 6.17% 16.26% 16.90%
Cash Return on Invested Capital (CROIC)
-200.47% 0.00% 13.80% 29.54% 50.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-3.74% 0.00% -1.07% -2.10% 0.00% 0.00% -2.41% -5.06% 1.64% 4.72% 6.17%
Return on Assets (ROA)
-2.97% 0.00% 2.59% -4.45% 0.00% 0.00% 4.74% 0.48% 4.67% 4.98% 7.19%
Return on Common Equity (ROCE)
-2.54% 0.00% 1.59% -12.77% -60.40% -39.89% -1.97% -9.97% 6.16% 16.24% 16.88%
Return on Equity Simple (ROE_SIMPLE)
5.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.63 1.57 -0.30 -1.25 -0.34 4.19 -0.47 -0.80 0.16 0.74 0.86
NOPAT Margin
-2.13% 0.00% -2.45% -9.88% -2.73% 0.00% -3.63% -6.00% 1.16% 4.88% 5.84%
Net Nonoperating Expense Percent (NNEP)
-0.40% -61.10% 12.30% -25.11% -29.72% -22.30% 7.81% 4.64% 3.64% 0.88% 1.66%
Return On Investment Capital (ROIC_SIMPLE)
- 5.87% -1.14% -5.36% -1.68% 23.34% -2.08% -3.43% 0.68% 4.90% 5.58%
Cost of Revenue to Revenue
8.84% 0.00% 22.20% 22.30% 22.24% 0.00% 22.73% 20.89% 19.89% 18.59% 18.37%
SG&A Expenses to Revenue
68.58% 0.00% 60.23% 61.80% 59.10% 0.00% 52.88% 58.37% 54.52% 50.61% 47.81%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
94.21% 0.00% 81.31% 91.81% 81.65% 0.00% 82.46% 87.68% 78.91% 76.52% 75.73%
Earnings before Interest and Taxes (EBIT)
-0.90 -1.53 -0.39 -1.70 -0.41 3.92 -0.49 -0.98 0.30 0.94 1.11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.44 0.16 1.01 -0.18 0.83 4.48 -0.10 -0.56 0.76 1.38 1.52
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.76 5.73 7.37 9.08 8.39 8.89 8.31 7.60 6.45 8.61 8.07
Price to Tangible Book Value (P/TBV)
7.29 5.73 13.42 18.53 10.58 8.89 8.31 7.60 6.45 8.61 8.07
Price to Revenue (P/Rev)
1.16 3.02 6.25 14.86 0.00 3.07 3.57 3.30 2.69 2.36 2.21
Price to Earnings (P/E)
62.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 75.69 44.59 38.57
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.32% 2.24% 2.59%
Enterprise Value to Invested Capital (EV/IC)
5.08 0.00 8.93 11.47 10.98 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
1.02 2.65 5.62 13.55 0.00 2.57 3.14 2.72 2.12 1.92 1.83
Enterprise Value to EBITDA (EV/EBITDA)
9.69 14.10 38.81 78.55 81.81 41.05 83.52 83.42 74.87 70.98 33.32
Enterprise Value to EBIT (EV/EBIT)
37.03 490.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 75.17
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 454.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 166.43
Enterprise Value to Operating Cash Flow (EV/OCF)
7.14 8.49 15.12 21.28 17.26 14.16 57.39 30.68 37.67 57.31 25.48
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 6.69 60.90 32.52 16.23 69.78 6.61 5.96 5.29 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.06 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.06 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.65 -0.72 -0.33 -0.32 -0.34 -1.45 -0.75 -0.83 -0.89 -1.59 -1.36
Leverage Ratio
2.82 3.15 3.01 3.10 3.20 3.92 3.38 3.35 3.45 4.03 3.60
Compound Leverage Factor
2.82 3.15 3.01 3.10 3.20 3.92 3.38 3.35 3.45 4.03 3.60
Debt to Total Capital
5.48% 7.47% 0.12% 0.11% 0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
5.48% 7.47% 0.12% 0.11% 0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.07% 0.09% 0.10% 0.11% 0.12% 0.14% 0.11% 0.11% 0.11% 0.17% 0.16%
Common Equity to Total Capital
94.46% 92.44% 99.78% 99.79% 99.79% 99.86% 99.89% 99.89% 99.89% 99.83% 99.84%
Debt to EBITDA
0.17 0.23 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-1.24 -1.95 -4.40 -7.62 -12.02 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.17 0.23 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-6.87 -0.15 0.08 -0.04 -0.06 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
50.71 1.28 -51.49 30.94 69.04 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-6.87 -0.15 0.08 -0.04 -0.06 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.25 1.64 2.11 1.96 1.46 2.15 2.58 2.76 2.64 2.46 2.64
Noncontrolling Interest Sharing Ratio
66.54% 0.00% 0.08% 0.09% 0.09% 0.12% 0.10% 0.11% 0.12% 0.14% 0.13%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.03 1.32 1.34 1.28 1.44 1.46 1.66 1.80 1.83 1.59 1.64
Quick Ratio
0.71 0.62 0.66 0.62 0.65 0.56 0.58 0.92 0.99 0.81 0.76
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-24 34 2.17 5.26 9.19 7.33 26 25 23 -0.26 0.05
Operating Cash Flow to CapEx
344.58% 290.14% 711.39% -370.98% 1,413.46% 1,452.97% -1,116.32% 172.00% 557.84% 829.27% -629.23%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.22 0.52 0.33 0.16 0.00 0.62 0.64 0.69 0.73 0.76 0.82
Accounts Receivable Turnover
0.00 14.47 9.09 3.98 0.00 20.09 17.02 16.79 15.13 20.20 21.32
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 14.89 0.00 0.00 0.00 17.25 18.56
Accounts Payable Turnover
0.00 4.97 6.87 6.80 5.90 7.67 10.23 7.29 7.46 6.72 11.07
Days Sales Outstanding (DSO)
0.00 25.22 40.16 91.62 0.00 18.17 21.45 21.74 24.12 18.07 17.12
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 73.49 53.13 53.71 61.91 47.62 35.67 50.07 48.91 54.29 32.98
Cash Conversion Cycle (CCC)
0.00 -48.27 -12.97 37.91 0.00 -29.45 -14.22 -28.33 -24.79 -36.22 -15.86
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
23 -8.03 19 17 14 -11 -7.33 -8.65 -8.83 -10 -6.51
Invested Capital Turnover
9.86 5.84 1.50 0.71 0.00 -5.41 8.79 13.23 22.73 -5.18 -8.19
Increase / (Decrease) in Invested Capital
23 -32 -2.47 -6.50 -9.54 -3.14 -27 -25 -22 1.00 0.82
Enterprise Value (EV)
118 125 173 192 150 133 167 146 116 105 104
Market Capitalization
133 142 193 211 172 159 190 177 146 130 125
Book Value per Share
$2.39 $1.68 $1.77 $1.55 $1.36 $1.20 $1.50 $1.52 $1.48 $1.01 $1.10
Tangible Book Value per Share
$1.23 $1.68 $0.97 $0.76 $1.08 $1.20 $1.50 $1.52 $1.48 $1.01 $1.10
Total Capital
37 27 26 23 20 18 23 23 23 15 15
Total Debt
2.04 2.00 0.03 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
2.04 2.00 0.03 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-15 -17 -20 -19 -22 -26 -23 -31 -31 -24 -21
Capital Expenditures (CapEx)
1.10 1.17 0.40 0.26 0.24 0.28 0.33 0.51 0.32 0.35 0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-16 -8.45 -8.38 -9.27 -5.11 -3.16 5.13 -2.76 -3.26 -5.03 -2.01
Debt-free Net Working Capital (DFNWC)
0.75 11 11 9.37 17 23 28 28 27 19 19
Net Working Capital (NWC)
0.75 11 11 9.37 17 23 28 28 27 19 19
Net Nonoperating Expense (NNE)
0.09 13 -1.25 2.35 2.82 6.90 -1.44 -0.89 -0.70 -0.25 -0.43
Net Nonoperating Obligations (NNO)
-12 -33 -6.80 -6.48 -6.85 -29 -30 -32 -32 -25 -22
Total Depreciation and Amortization (D&A)
2.35 1.69 1.40 1.52 1.24 0.56 0.39 0.42 0.46 0.44 0.40
Debt-free, Cash-free Net Working Capital to Revenue
-14.28% -17.99% -27.16% -65.48% 0.00% -6.08% 9.66% -5.16% -5.99% -9.16% -3.54%
Debt-free Net Working Capital to Revenue
0.65% 22.91% 36.57% 66.18% 0.00% 44.01% 52.82% 52.84% 50.43% 35.11% 34.29%
Net Working Capital to Revenue
0.65% 22.91% 36.57% 66.18% 0.00% 44.01% 52.82% 52.84% 50.43% 35.11% 34.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.05) ($0.75) $0.06 ($0.24) ($0.21) ($0.18) $0.00 $0.01 $0.06 $0.06 $0.09
Adjusted Weighted Average Basic Shares Outstanding
14.79M 14.69M 14.80M 14.95M 14.96M 14.92M 0.00 15.33M 15.34M 15.13M 14.18M
Adjusted Diluted Earnings per Share
($0.05) ($0.74) $0.06 ($0.24) ($0.21) ($0.17) $0.00 $0.01 $0.06 $0.06 $0.09
Adjusted Weighted Average Diluted Shares Outstanding
15.02M 14.94M 15.01M 15.21M 15.19M 15.15M 0.00 15.40M 15.40M 15.19M 14.19M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
14.75M 14.78M 14.97M 15.00M 14.98M 15.17M 0.00 15.34M 14.87M 14.11M 14.26M
Normalized Net Operating Profit after Tax (NOPAT)
0.00 0.82 -0.30 -1.25 -0.34 -1.22 -0.47 -0.79 0.16 0.74 0.89
Normalized NOPAT Margin
0.02% 0.00% -2.45% -9.87% -2.71% 0.00% -3.62% -5.98% 1.16% 4.89% 6.01%
Pre Tax Income Margin
-3.07% 0.00% -3.20% -13.47% -3.23% 0.00% -3.77% -7.37% 2.25% 6.20% 7.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.19% -0.04% -0.07% -0.07% 0.00% -0.11% 0.11% -0.17% 118.86% 389.15% 384.69%

Financials Breakdown Chart

Key Financial Trends

Joint Corp. (NASDAQ: JYNT) showed a much stronger operating profile in Q1 2026 than it did a year ago, but the balance sheet and cash flow still carry some important watch items. Revenue held up well, gross margins remained healthy, and the company posted positive net income. However, operating cash flow was negative in the quarter, and liabilities remain elevated relative to equity.

  • Revenue growth held up year over year. Q1 2026 revenue was $14.8 million, up from $13.1 million in Q1 2025, showing the business is still growing after the 2024 downturn.
  • Gross profit remained strong. Gross profit in Q1 2026 was $12.1 million, with gross margin near 82%, which suggests the core service model still generates attractive unit economics.
  • Operating profitability improved sharply from last year’s weak periods. Q1 2026 operating income was $0.9 million versus an operating loss in Q1 2025 and much larger losses in 2024 and late 2023.
  • Net income was positive. The company reported $1.3 million in consolidated net income in Q1 2026, compared with a loss in several prior quarters in 2024.
  • Cash on hand remains meaningful. Joint ended Q1 2026 with $20.7 million in cash and equivalents, plus $0.7 million in restricted cash.
  • Equity improved from last year’s trough. Total common equity rose to $15.5 million from $22.7 million in Q3 2025, but that was after a large earlier erosion in 2024 and before the Q1 2026 decline in cash.
  • Marketing and SG&A remain large cost centers. Q1 2026 SG&A was $7.1 million and marketing expense was $3.7 million, both still taking up a large share of revenue.
  • Discontinued operations continue to distort reported earnings. A meaningful portion of reported net income in several quarters came from discontinued operations, which makes year-to-year comparisons less clean.
  • Operating cash flow was negative in Q1 2026. The company used $1.5 million in operating cash, and total cash declined by $2.9 million during the quarter.
  • Liabilities remain high. Total liabilities were $42.4 million at Q1 2026 versus $15.5 million of equity and noncontrolling interest, so leverage remains an important concern.

Trend summary: Joint’s recent results suggest a recovery in the underlying business versus the weak 2024 period, when revenue collapsed and losses widened dramatically. The recovery continued into 2025 and Q1 2026, with better margins and positive earnings. Still, investors should watch whether the company can translate accounting profits into consistent operating cash flow, since cash generation has been uneven and balance sheet obligations remain substantial.

07/27/26 10:41 AM ETAI Generated. May Contain Errors.

Joint Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Joint's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Joint's net income appears to be on a downward trend, with a most recent value of $2.91 million in 2025, falling from -$8.80 million in 2015. The previous period was -$5.80 million in 2024. See Joint's forecast for analyst expectations on what's next for the company.

Joint's total operating income in 2025 was -$913.38 thousand, based on the following breakdown:
  • Total Gross Profit: $43.67 million
  • Total Operating Expenses: $44.58 million

Over the last 10 years, Joint's total revenue changed from $13.84 million in 2015 to $54.90 million in 2025, a change of 296.8%.

Joint's total liabilities were at $45.89 million at the end of 2025, a 26.6% decrease from 2024, and a 261.8% increase since 2015.

In the past 10 years, Joint's cash and equivalents has ranged from $3.01 million in 2016 to $25.05 million in 2024, and is currently $23.60 million as of their latest financial filing in 2025.

Over the last 10 years, Joint's book value per share changed from 2.09 in 2015 to 1.01 in 2025, a change of -51.5%.



Financial statements for NASDAQ:JYNT last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners